Author | Michael R. Page, PharmD, RPh

Articles

Reactivation of Hepatitis B Associated With Immunosuppressive Medications

May 29, 2015

Article

In patients with chronic HBV, the immune system may have very low levels of the virus. When reactivation occurs due to immunosuppression, these viruses begin to replicate again. Common symptoms of this event include inflammation of the liver and elevations of liver enzyme levels in the blood. In some cases, bilirubin levels may rise in response to reactivation of infection.

Product Profile: Lemtrada (alemtuzumab)

April 09, 2015

Article

Lemtrada (alemtuzumab) injection is approved for the management of relapsing forms of multiple sclerosis (MS). In general, use of Lemtrada should be limited to patients with MS who have not had therapeutic success with 2 or more prior treatments.

Teriflunomide Is First Oral Regimen Proved to Delay Onset of Clinically Definite Multiple Sclerosis

February 16, 2015

Article

For the first time, an oral therapy has been proved to reduce the risk of developing clinically definite multiple sclerosis in patients with a clinically isolated syndrome.

Study Suggests Multiple Sclerosis and Salt Intake May Be Related

February 16, 2015

Article

Increased salt intake may magnify the risk of relapses in patients with multiple sclerosis (MS). According to researchers, excess dietary sodium intake is associated with a higher level of disease activity in patients with relapsing-remitting MS.

x